Genetic Analysis of c-MYC Overexpression and Cancer Risk
Author Information
Author(s): Solé Xavier, Hernández Pilar, de Heredia Miguel López, Armengol Lluís, Rodríguez-Santiago Benjamín, Gómez Laia, Maxwell Christopher A, Aguiló Fernando, Condom Enric, Abril Jesús, Pérez-Jurado Luis, Estivill Xavier, Nunes Virginia, Capellá Gabriel, Gruber Stephen B, Moreno Víctor, Pujana Miguel Angel
Primary Institution: Catalan Institute of Oncology, IDIBELL, L'Hospitalet, Barcelona, Spain
Hypothesis
Variation at 8q24 cis-regulator(s) of transcription can significantly alter germline c-MYC expression levels and contribute to cancer susceptibility.
Conclusion
The study suggests that germline c-MYC overexpression may promote prostate cancer susceptibility by down-regulating the tumor suppressor KLF6 gene.
Supporting Evidence
- Genetic variation at 8q24 has been associated with prostate cancer risk.
- c-MYC overexpression correlates with more aggressive forms of prostate cancer.
- Significant SNPs were identified that associate with c-MYC expression levels.
Takeaway
This study found that changes in a specific gene can make people more likely to get prostate cancer by affecting another important gene that helps prevent cancer.
Methodology
The study used genetic association scans and expression profiling in normal prostate tissues to analyze c-MYC expression and its association with prostate cancer risk.
Limitations
The genetic scanning analysis is susceptible to false positives, and larger sample sizes are needed for definitive conclusions.
Participant Demographics
The study included individuals of European ancestry and African Americans.
Statistical Information
P-Value
0.004
Confidence Interval
0.06 – 0.41
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website